There are seven businesses worth watching as they attempt to capitalize on the numerous business opportunities in the global marijuana market for entrepreneurs and companies with ambition. And check mjbizdaily.com/intl often for new updates. Looking for where else the action is taking place in the global cannabis market? Here is our list of seven countries to keep […]
Read More
Cannabis in Latin America: The Regulations and Opportunities
Intended for investors and business operators looking to enter or expand operations in the region, this in-depth exploration of cannabis business markets and sectors across Latin America and the Caribbean provides extensive, unbiased data and analysis.
More Exclusive Features
Global Cannabis: Q&A with Kim Campbell
As the first country to regulate medical and adult-use cannabis at a federal level, Canada has an opportunity to be the leading force in setting standards for other nations to follow, according to former Canadian Prime Minister Kim Campbell. She said integrity of businesses, the regulators and products all are key to the long-term success […]
Read More
Global Cannabis: Q&A with Vicente Fox
For years, former Mexican President Vicente Fox was bullish on launching a legal medical marijuana market in the country he led for half a decade. And now? He’s less optimistic. “I moved from very optimistic time-wise to neutral, because I don’t see things happening. But it will happen very soon. I don’t have any doubt,” […]
Read More
Global Cannabis: 12 Notable Countries
With every passing day, the cannabis industry becomes more of an international market. The September issue of Marijuana Business Magazine focused on 12 notable countries that already offer plant-touching business opportunities in cultivation, retail, exports and sales, among other areas. Ancillary opportunities from legal services to equipment sales also abound. Learn how these 12 nations are embracing marijuana […]
Read More
Global Cannabis: Growing Momentum
The emergence of more overseas cannabis markets offers companies billions of dollars in business opportunities Momentum continues to build for medical cannabis legalization around the globe, prying open new markets and tens of billions of dollars in business opportunities for entrepreneurs and companies with global ambitions. Business prospects can be divided into two categories: current […]
Read More
Global Cannabis: Brazil
Milestones in the Medical Cannabis Program The National Sanitary Surveillance Agency regulated “compassionate use” imports in 2015. Key Laws and Regulations RDC No. 17/2015 Portaria 344/1998 Market Data Since 2014, almost 10,000 authorizations were granted to individual patients, allowing them to import medical cannabis on a case-by-case basis, each for a period of […]
Read More
Global Cannabis: Colombia
Milestones in the Medical Cannabis Program The government finalized its medical marijuana law in 2016, but as of today, no MMJ products are available in the domestic market. High-THC cannabis has been exported only for analytical purposes as of mid-2019. Key Laws and Regulations Law 1787: July 6, 2016 Decree 613: April 10, 2017 […]
Read More
Global Cannabis: The Netherlands
Milestones in the Medical Cannabis Program The Office of Medical Cannabis was created in 2001, and the first products became available in Dutch pharmacies in fall 2003. Key Laws and Regulations Opium Act Market Data A centralized registry of patients does not exist. About 550 kilograms (1,213 pounds) of flower were sold in […]
Read More
Global Cannabis: Zimbabwe
Milestones in the Medical Cannabis Program Zimbabwe legalized the cultivation of cannabis for medicinal and scientific purposes in 2018, making it the second country in Africa to lay the groundwork for a medical marijuana industry. The law defined how companies could become licensed producers and ship medical cannabis to “authorized recipients.” Key Laws and Regulations […]
Read More
Global Cannabis: Australia
Milestones in the Medical Cannabis Program The first cultivation license was issued in 2018. Key Laws and Regulations Narcotic Drugs Act of 1967 (and 2016 amendment) Therapeutic Goods Act of 1989 Therapeutic Goods Regulations of 1990 Special Access Scheme Market Data Cumulative patient approvals topped 9,300 as of June. Though the number seems […]
Read More
Business can expect new markets, fresh opportunities - and more pitfalls.